Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
127,009,800
-
Shares change
-
-30,586
-
Total reported value, excl. options
-
$1,641,067,539
-
Value change
-
+$3,819,921
-
Put/Call ratio
-
24%
-
Number of buys
-
102
-
Number of sells
-
-98
-
Price
-
$12.92
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q2 2023
240 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q2 2023.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127,009,800 shares
.
Largest 10 shareholders include BlackRock Inc. (19,183,847 shares), FEDERATED HERMES, INC. (12,655,363 shares), VANGUARD GROUP INC (8,876,161 shares), STATE STREET CORP (7,788,367 shares), Deep Track Capital, LP (6,557,816 shares), Chicago Capital, LLC (5,810,468 shares), Fisher Asset Management, LLC (3,900,949 shares), GOLDMAN SACHS GROUP INC (3,592,267 shares), DIMENSIONAL FUND ADVISORS LP (3,539,385 shares), and PFM Health Sciences, LP (2,704,917 shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.